Utility of metformin in breast cancer treatment, is neoangiogenesis a risk factor?

Abstract

To the Editor There is growing evidence that metformin (a biguanide derivative used to treat type 2 diabetes) may impede the growth of human tumors, including breast cancers. A recent report in this journal raises a potentially important issue regarding the utility and safety of metformin as a therapy for breast cancer. While metformin was found to be… (More)
DOI: 10.1007/s10549-008-0015-4

Topics

  • Presentations referencing similar topics